London, , GB
Mid-Sized Business (10-100M TTM Revenue)
Headquartered in Needham, MA, Invicro, a subsidiary of REALM IDx, was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development. Today, Invicro’s multi-disciplinary team provides solutions to pharmaceutical and biotech companies across all stages of the drug development pipeline (Preclinical through Phase 0-IV), all imaging modalities and all therapeutic areas. Invicro’s quantitative biomarker services, pathology solutions, advanced analytics and AI tools, and clinical operational services are backed by Invicro’s industry-leading software informatics platforms, VivoQuant® and iPACS®, as well as their pioneering IQ Analytics Platform, which includes Amyloid-IQ, Tau-IQ and DaT-IQ.
Invicro operates out of nine global laboratories, clinics and sites within the United States in Massachusetts, Michigan, California, Connecticut and globally in the United Kingdom, India, Japan and China.
Learn more by visiting www.invicro.com
|Invicro LLC 115 4th Ave Needham, MA, 02494 United States|
|APS CAP/CLIA Lab 1 Enterprise, Suite 1F Aliso Viejo, California, 92656 United States|
|Imanova Ltd Burlington Danes Building London, , W12 0NN United Kingdom|
|Invicro, Molecular Imaging Center (MIC) Sanford Consortium for Regenerative Medicine La Jolla, California, 92037 United States|
|Invicro LLC Richard Coelho Durham, NC, 27709 United States|
|Invicro LLC 119 Fourth Ave Needham, MA, 02494 United States|
|Imanova Ltd, Trading as Invicro Burlington Danes Building London, , W12 0NN United Kingdom|
|Invicro 60 Temple Street New Haven, CT, 06510 United States|
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order product instantly, request access below.